GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Rohto Pharmaceutical Co Ltd (TSE:4527) » Definitions » Purchase Of Property, Plant, Equipment

Rohto Pharmaceutical Co (TSE:4527) Purchase Of Property, Plant, Equipment : 円0 Mil (TTM As of Dec. 2023)


View and export this data going back to 1962. Start your Free Trial

What is Rohto Pharmaceutical Co Purchase Of Property, Plant, Equipment?

Rohto Pharmaceutical Co's purchase of property, plant, equipment for the three months ended in Dec. 2023 was 円0 Mil. It means Rohto Pharmaceutical Co spent 円0 Mil on purchasing property, plant, equipment. Rohto Pharmaceutical Co's purchase of property, plant, equipment for the trailing twelve months (TTM) ended in Dec. 2023 was 円0Mil.

Compared with last quarter (円0 Mil in Sep. 2023 ), Rohto Pharmaceutical Co spent the same money on purchasing property, plant, equipment in Dec. 2023 (円0 Mil).


Rohto Pharmaceutical Co Purchase Of Property, Plant, Equipment Historical Data

The historical data trend for Rohto Pharmaceutical Co's Purchase Of Property, Plant, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rohto Pharmaceutical Co Purchase Of Property, Plant, Equipment Chart

Rohto Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Purchase Of Property, Plant, Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5,586.00 -8,721.00 -10,267.00 -8,473.00 -7,979.00

Rohto Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Purchase Of Property, Plant, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Rohto Pharmaceutical Co Purchase Of Property, Plant, Equipment Calculation

The amount used to purchase PPE.

Purchase Of Property, Plant, Equipment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rohto Pharmaceutical Co Purchase Of Property, Plant, Equipment Related Terms

Thank you for viewing the detailed overview of Rohto Pharmaceutical Co's Purchase Of Property, Plant, Equipment provided by GuruFocus.com. Please click on the following links to see related term pages.


Rohto Pharmaceutical Co (TSE:4527) Business Description

Traded in Other Exchanges
Address
1-8-1, Tatsumi-nishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based manufacturer and marketer of pharmaceutical products, cosmetics, and functional foods. It undertakes manufacture and sales activities mainly in the health and beauty care categories. The company comprises the four geographical reportable segments of Japan, America, Europe, and Asia. In each segment, it manufactures and sales eye care products including eye drops and eyewash preparations, skincare products including dermal medicines, lip balm, sunscreens, and functional cosmetics, among others, internal medicines and food products including gastrointestinal medicines, traditional Chinese herbal medicines and supplements, and other products and services, such as in-vitro test kits.

Rohto Pharmaceutical Co (TSE:4527) Headlines

No Headlines